Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors (Q30370204)

16 October 2017

Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors (English)

1 reference

16 October 2017

1 reference

23

1 reference

16 October 2017

Anne S Reiner

2

0 references

Lisa M DeAngelis

object named as

Lisa M DeAngelis

25

0 references

Patrick Y Wen

14

object named as

Patrick Y Wen

1 reference

16 October 2017

4

Timothy F Cloughesy

1 reference

16 October 2017

9

Nina A Paleologos

1 reference

16 October 2017

24

Lauren E Abrey

1 reference

16 October 2017

12

J Gregory Cairncross

1 reference

16 October 2017

1

Katherine S Panageas

1 reference

16 October 2017

Fabio M Iwamoto

3

1 reference

16 October 2017

Kenneth D Aldape

5

1 reference

16 October 2017

Andreana L Rivera

6

1 reference

16 October 2017

April F Eichler

7

1 reference

16 October 2017

David N Louis

8

1 reference

16 October 2017

Barbara J Fisher

10

1 reference

16 October 2017

Lynn S Ashby

11

1 reference

16 October 2017

Gloria B Roldán Urgoiti

13

1 reference

16 October 2017

Keith L Ligon

15

1 reference

16 October 2017

David Schiff

16

1 reference

16 October 2017

H Ian Robins

17

1 reference

16 October 2017

Brandon G Rocque

18

1 reference

16 October 2017

Marc C Chamberlain

19

1 reference

16 October 2017

Warren P Mason

20

1 reference

16 October 2017

Susan A Weaver

21

1 reference

16 October 2017

Richard M Green

22

1 reference

16 October 2017

Suresh C Jhanwar

26

1 reference

16 October 2017

Marc K Rosenblum

27

1 reference

16 October 2017

Andrew B Lassman

28

1 reference

16 October 2017

4 July 2014

1 reference

16 October 2017

1 reference

16 October 2017

16

1 reference

16 October 2017

11

1 reference

16 October 2017

1541-1546

1 reference

MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951.

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Molecular neuro-oncology in clinical practice: a new horizon

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Interlaboratory comparison of IDH mutation detection.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EOR

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Initial treatment patterns over time for anaplastic oligodendroglial tumors

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Molecular subclassification of diffuse gliomas: seeing order in the chaos

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Survey of treatment recommendations for anaplastic oligodendroglioma

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

3 June 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOU083

What is an oligodendroglioma?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4201067

26 November 2018

Identifiers

DOI

10.1093/NEUONC/NOU083

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

24997140

1 reference